Non Vascular Stents Market Share, Growth & Demand by 2034

Non Vascular Stents Market Size and Forecasts (2021 - 2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Product Type (Gastrointestinal Stents, Pulmonary Stents, Urological Stents); Material Type (Metallic Stents, Non-metallic Stents); End User (Hospitals and Ambulatory Surgical Centers) ; and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00040719
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 17, 2026
Non Vascular Stents Market Share, Growth & Demand by 2034
Report Date: April 17, 2026   |   Report Code: TIPRE00040719 Email: sales@theinsightpartners.com

2025 Market Size

US$ 5.4 Bn

Base year value

2034 Forecast

US$ 8.15 Bn

Projected by 2034

CAGR 2026-2034

4.68 %

Growth rate

Addressable Market

US$ 61.51 Bn

(2026-2034)

The global non vascular stents market size is projected to reach US$ 8.15 billion by 2034 from US$ 5.4 billion in 2025. The market is anticipated to register a CAGR of 4.68% during the forecast period 2026-2034.

The report is segmented by Product Type (Gastrointestinal Stents, Pulmonary (Airway) Stents, Urological Stents, Others), Material Type (Metallic Stents, Non-metallic Stents), End-User (Hospitals and Ambulatory Surgical Centers)

Purpose of the Report

The report Non Vascular Stents Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Non Vascular Stents Market Segmentation

Product Type

  • Gastrointestinal Stents
  • Pulmonary Stents
  • Urological Stents

Material Type

  • Metallic Stents
  • Non-metallic Stents

End User

  • Hospitals and Ambulatory Surgical Centers

Market Research Highlights

  • Global market for Non Vascular Stents was valued at US$ 5.40 Billion in 2025
  • Annual market size is expected to reach US$ 8.15 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 61.51 Billion
  • Market is anticipated to register a CAGR of 4.68% during the forecast period
  • The United States represents a key market, supported by Increasing Prevalence of Chronic Diseases, Technological Advancements in Stent Materials, Rising Geriatric Population, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expansion in Emerging Markets, Integration of Smart Technology, Increase in Non-Vascular Stenting for Cancer Treatment are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Boston Scientific, Medtronic, Abbott Laboratories, Cook Medical, Terumo Corporation, B. Braun Melsungen, Johnson & Johnson, EndoChoice, C. R. Bard, Merit Medical Systems, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Non Vascular Stents Market: Strategic Insights

non-vascular-stents-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Non Vascular Stents Market Growth Drivers

  • Increasing Prevalence of Chronic Diseases:The rising prevalence of chronic conditions such as cancer, gastrointestinal disorders, and respiratory diseases is driving the demand for non-vascular stents. These stents are essential for maintaining the patency of airways and gastrointestinal passages, thus improving patient quality of life and increasing the demand for these devices in clinical settings worldwide.
  • Technological Advancements in Stent Materials:Technological innovations in stent materials, such as biocompatible, flexible, and durable materials, are driving the growth of the non-vascular stents market. These advancements improve the performance and safety of non-vascular stents, leading to better patient outcomes and the adoption of stents in a broader range of medical applications, including airway and bile duct stenting.
  • Rising Geriatric Population:The global increase in the geriatric population is contributing significantly to the demand for non-vascular stents. Elderly individuals are more susceptible to chronic diseases such as cancer and gastrointestinal issues, which often require stent placement. As this demographic continues to grow, the market for non-vascular stents is expected to expand, driven by the need for effective treatments for these conditions.

Non Vascular Stents Market Future Trends

  • Minimally Invasive Procedures:There is a growing trend towards minimally invasive procedures, which is driving the adoption of non-vascular stents. These stents can be inserted with minimal incisions, reducing recovery times and the risk of complications. This trend is appealing to both patients and healthcare providers, as it promotes faster healing and shorter hospital stays.
  • Development of Biodegradable Stents:The development of biodegradable non-vascular stents is an emerging trend in the market. These stents gradually dissolve over time, reducing the need for surgical removal and minimizing long-term complications. Biodegradable stents are particularly beneficial for conditions such as airway obstruction and gastrointestinal issues, where temporary support is needed.
  • Shift Toward Personalized Medicine:Personalized medicine is influencing the non-vascular stents market, with an increasing focus on developing stents tailored to individual patients' needs. This trend is driven by advancements in diagnostics, which allow for more precise treatment planning, improving the outcomes of stent implantation procedures and enhancing the patient's overall experience.

Non Vascular Stents Market Opportunities

  • Expansion in Emerging Markets:
    There is a significant opportunity for the growth of the non-vascular stents market in emerging regions like Asia-Pacific, Latin America, and the Middle East. With improving healthcare infrastructure and increased awareness, these regions present untapped markets for stent manufacturers looking to expand their reach.
  • Integration of Smart Technology:
    The integration of smart technologies, such as sensors and monitoring devices, into non-vascular stents presents a unique opportunity. Smart stents can provide real-time feedback on the condition of the stent or the surrounding tissue, enhancing treatment outcomes and allowing for better patient monitoring, which is particularly valuable in complex cases.
  • Increase in Non-Vascular Stenting for Cancer Treatment:
    The rising prevalence of cancer, particularly esophageal and bile duct cancers, is driving demand for non-vascular stents. These stents are used to alleviate obstruction and improve the quality of life for cancer patients. As cancer rates rise, there is a significant opportunity to expand the use of non-vascular stents for palliative care.

Non Vascular Stents Market Report Scope

Report Attribute Details
Market size in 2025 US$ 5.4 Billion
Market Size by 2034 US$ 8.15 Billion
Global CAGR (2026 - 2034) 4.68%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product Type
  • Gastrointestinal Stents
  • Pulmonary Stents
  • Urological Stents
By Material Type
  • Metallic Stents
  • Non-metallic Stents
By End User
  • Hospitals and Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Cook Medical
  • Terumo Corporation
  • B. Braun Melsungen
  • Johnson & Johnson
  • EndoChoice
  • C. R. Bard
  • Merit Medical Systems

Non Vascular Stents Market Players Density: Understanding Its Impact on Business Dynamics

The Non Vascular Stents Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

non-vascular-stents-market-cagr

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Non Vascular Stents Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Non Vascular Stents Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The primary drivers include the increasing prevalence of chronic diseases, technological advancements in stent materials, and the rising geriatric population, which contributes to a higher demand for non-vascular stenting procedures.

Minimally invasive procedures are driving the adoption of non-vascular stents due to their benefits, including reduced recovery time, fewer complications, and shorter hospital stays, making stent implantation a preferred treatment option.

Biodegradable stents, which dissolve over time, reduce the need for removal surgery and minimize long-term complications, driving their adoption in applications like airway and gastrointestinal stenting, enhancing patient comfort and safety.

Emerging markets present significant growth opportunities for non-vascular stents, driven by improving healthcare infrastructure, increasing awareness, and rising healthcare access in regions like Asia-Pacific, Latin America, and the Middle East.

Personalized medicine is influencing the market by pushing for stents tailored to individual patient needs. This trend, powered by advancements in diagnostics, aims to improve treatment outcomes and enhance patient care during stent implantation procedures.

Non-vascular stents are increasingly used for cancer patients to alleviate obstructions in areas like the esophagus and bile ducts, improving the quality of life for those with cancer by enabling better digestion and breathing while reducing symptoms.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA